TD Private Client Wealth’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-12
Closed -$855 1252
2021
Q3
$855 Hold
12
﹤0.01% 1120
2021
Q2
$617 Buy
+12
New +$374 ﹤0.01% 1156

Other funds holding PRTA

TD Private Client Wealth's PRTA Position: Q4 2021 in Review

TD Private Client Wealth sold out of Prothena Corp (PRTA) in Q4 2021, closing a stake of 12 shares — an estimated $855 sold.

TD Private Client Wealth first reported a position in PRTA in Q2 2021 and held it in 2 quarters. The position peaked at $855 in Q3 2021. 196 funds tracked by Wall St. Rank hold PRTA as of Q4 2021.

  • TD Private Client Wealth reported no remaining Prothena Corp position as of Q4 2021 after selling out during the quarter.
  • TD Private Client Wealth sold 12 Prothena Corp shares in Q4 2021, an estimated $855.
  • TD Private Client Wealth first reported a position in Prothena Corp in Q2 2021 and held it in 2 quarters.
  • TD Private Client Wealth's Prothena Corp position peaked at $855 in Q3 2021.
  • 196 funds tracked by Wall St. Rank held Prothena Corp as of Q4 2021.

Based on TD Private Client Wealth's 13F filing for Q4 2021, filed 16 Aug 2024.